Charles River Laboratories (NYSE:CRL)

CAPS Rating: 4 out of 5

The Company is a global provider of solutions that advance the drug discovery and development process. It provides the animal research models required in research and development for new drugs, devices and therapies.

Recs

0
Player Avatar nashte1 (< 20) Submitted: 6/18/2008 3:43:41 PM : Outperform Start Price: $64.11 CRL Score: -49.81

oil is king

Featured Broker Partners


Advertisement